Related Experiment Video
Updated: May 19, 2026
09:15
Measuring Pressure Volume Loops in the Mouse
Published on: May 2, 2016
CDCP1 Deletion Protects Against Pressure Overload-Induced Cardiac Dysfunction and Fibrosis in Mice.
Naveen Pereira1, Rachad Ghazal1, Akshatha N Srinivas1
1Mayo Clinic.
Research Square
|May 18, 2026
Summary
Reduced CUB domain-containing protein 1 (CDCP1) expression mitigates cardiac fibrosis and improves heart recovery. This study demonstrates CDCP1
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Fibrosis Research
Background:
- Reduced CUB domain-containing protein 1 (CDCP1) expression is linked to improved myocardial recovery in heart failure patients.
- CDCP1's role in in vivo cardiac fibrosis is not well understood, despite its in vitro effects on cardiac fibroblast proliferation.
Purpose of the Study:
- To investigate the in vivo role of CDCP1 in cardiac fibrotic remodeling and heart failure progression.
Main Methods:
- Utilized a Cdcp1-knockout mouse model subjected to pressure overload (angiotensin II/phenylephrine).
- Performed echocardiography, histologic analysis, gene expression profiling, and spatial transcriptomics.
- Conducted complementary studies involving CDCP1 knockdown in human ventricular fibroblasts.
Main Results:
- Cdcp1 deletion attenuated cardiac fibrosis, reduced left ventricular mass, and decreased pro-fibrotic gene expression.
- Spatial transcriptomics revealed reduced fibroblast activation (FB5) and pro-inflammatory cardiomyocyte populations (CM4) in Cdcp1-knockout hearts.
- CDCP1 knockdown in human fibroblasts decreased extracellular matrix gene expression and collagen I deposition.
Conclusions:
- CDCP1 is a key regulator of cardiac fibrotic remodeling in vivo.
- Targeting CDCP1 may offer a novel therapeutic strategy for heart failure treatment.
Related Concept Videos
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...